4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Cardiac Regeneration
Recent advancements in cardiac regeneration research have led to innovative therapies that aim to enhance the healing process after cardiac injury. Preclinical studies and early-phase clinical trials are exploring the safety and efficacy of various regenerative approaches. These may involve the transplantation of stem cells, the use of growth factors to stimulate tissue repair, or the development of bioengineered cardiac patches that can be implanted to replace damaged tissue. The ultimate goal is to develop interventions that not only repair the structural damage caused by heart diseases but also restore optimal cardiac function. While challenges and complexities remain, the potential for cardiac regeneration to transform the landscape of cardiovascular medicine is driving continued research and collaboration among scientists, clinicians, and experts in regenerative medicine.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Sana Tariq
Manchester University NHS Foundation Trust, United Kingdom
Achi Kamaraj
Royal Brisbane and Women’s Hospital, Austria
Agustin Joison
Cordoba Catholic University, ArgentinaSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom